Cargando…
Rikkunshi-to attenuates adverse gastrointestinal symptoms induced by fluvoxamine
BACKGROUND: Upper gastrointestinal (GI) symptoms such as nausea and vomiting are common adverse events associated with selective serotonin reuptake inhibitors (SSRIs), and may result in discontinuation of drug therapy in patients with depressive disorder. Rikkunshi-to (formulation TJ-43), a traditio...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2007
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2204024/ https://www.ncbi.nlm.nih.gov/pubmed/18001480 http://dx.doi.org/10.1186/1751-0759-1-21 |